Capstone Capital Management Ltd Acquires Shares of 100,324 Direxion Daily S&P Biotech Bear 3x Shares $LABD

Capstone Capital Management Ltd acquired a new position in shares of Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 100,324 shares of the company’s stock, valued at approximately $1,635,000. Direxion Daily S&P Biotech Bear 3x Shares makes up about 1.6% of Capstone Capital Management Ltd’s investment portfolio, making the stock its 17th biggest position.

Other institutional investors and hedge funds also recently modified their holdings of the company. Quadrature Capital Ltd acquired a new stake in shares of Direxion Daily S&P Biotech Bear 3x Shares in the fourth quarter valued at about $245,000. Jump Financial LLC acquired a new position in Direxion Daily S&P Biotech Bear 3x Shares during the 4th quarter worth approximately $2,966,000. Simplex Trading LLC acquired a new position in Direxion Daily S&P Biotech Bear 3x Shares during the 4th quarter worth approximately $48,000. JPMorgan Chase & Co. boosted its holdings in Direxion Daily S&P Biotech Bear 3x Shares by 655.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 6,803 shares of the company’s stock worth $275,000 after acquiring an additional 5,903 shares during the period. Finally, Scientech Research LLC purchased a new position in Direxion Daily S&P Biotech Bear 3x Shares in the 3rd quarter worth approximately $290,000.

Direxion Daily S&P Biotech Bear 3x Shares Stock Up 1.4%

Shares of NYSEARCA:LABD opened at $7.02 on Thursday. The company has a 50 day moving average of $12.34 and a two-hundred day moving average of $16.10. Direxion Daily S&P Biotech Bear 3x Shares has a 52-week low of $6.84 and a 52-week high of $69.69.

Direxion Daily S&P Biotech Bear 3x Shares Company Profile

The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion.